These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Accumulation and loss of noradrenaline central to a constriction on adrenergic nerves. Boyle FC; Gillespie JS Eur J Pharmacol; 1970 Sep; 12(1):77-84. PubMed ID: 5472268 [No Abstract] [Full Text] [Related]
28. Inhibitory effect of manganese on norepinephrine release from the splenic nerves of cats. Kirpekar SM; Dixon W; Prat JC J Pharmacol Exp Ther; 1970 Jul; 174(1):72-6. PubMed ID: 5424705 [No Abstract] [Full Text] [Related]
29. The effects of L9394 on adrenergic transmission in the cat spleen [proceedings]. Baco ZM; Blakeley AG; Summers RJ Br J Pharmacol; 1977 Jun; 60(2):286P. PubMed ID: 195662 [No Abstract] [Full Text] [Related]
31. Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system. Langer SZ Med Biol; 1974 Dec; 52(6):372-83. PubMed ID: 4374612 [No Abstract] [Full Text] [Related]
32. [Neurochemical and neurophysiological mechanisms of the psychostimulant action of phenamine]. Arushanian EB Farmakol Toksikol; 1975; 38(1):111-20. PubMed ID: 163205 [No Abstract] [Full Text] [Related]
33. Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation. Dubocovich ML; Langer SZ J Pharmacol Exp Ther; 1976 Jul; 198(1):83-101. PubMed ID: 933013 [TBL] [Abstract][Full Text] [Related]
34. Evidence that guanethidine does not block adrenergic nerves by acting as a false transmitter. Morgan DH; Oates JA; Shand DG Br J Pharmacol; 1970 May; 39(1):186P-187P. PubMed ID: 4315986 [No Abstract] [Full Text] [Related]
35. On the mechanism of supersensitivity to norepinephrine in the denervated cat spleen. Brimijoin S; Pluchino S; Trendelenburg U J Pharmacol Exp Ther; 1970 Nov; 175(2):503-13. PubMed ID: 5481714 [No Abstract] [Full Text] [Related]
36. [Etiology of schizophrenia: neurochemical aspects]. de las Cuevas Castresana C; González de Rivera JL Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627 [No Abstract] [Full Text] [Related]
37. Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. Kopin IJ; Breese GR; Krauss KR; Weise VK J Pharmacol Exp Ther; 1968 Jun; 161(2):271-8. PubMed ID: 5650139 [No Abstract] [Full Text] [Related]
38. Inhibitory effect of low pH on norepinephrine release. Puig M; Kirpekar SM J Pharmacol Exp Ther; 1971 Jan; 176(1):134-8. PubMed ID: 5569631 [No Abstract] [Full Text] [Related]
39. Biochemical pharmacology of catecholamines and its clinical implications. Axelrod J Trans Am Neurol Assoc; 1971; 96():179-86. PubMed ID: 4400652 [No Abstract] [Full Text] [Related]
40. Nerve stimulation-meditated overflow of norepinephrine and dopamine-beta-hydroxylase. III. Effects of norepinephrine depletion on the alpha presynaptic regulation of release. Cubeddu L; Weiner N J Pharmacol Exp Ther; 1975 Jan; 192(1):1-14. PubMed ID: 235629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]